It is great to see this device that I developed and validated during my DPhil being manufactured. How time flies! Thanks to everyone who made this possible.
We are pleased that OSSKAR, a medical device we have developed & validated, is now available. It positions the lower limb for valgus/varus stress imaging of the knee using a standardised technique without the need for a clinician to be present #OxfordKnee https://t.co/IaAo6UCtFy
DPhil student @LachieArthur is studying instrumentation improvements for the #OxfordKnee and has designed a survey to get surgeon feedback on instruments. Responses from Oxford Knee users, inc trainees, are welcomed! Survey link📢https://t.co/k0pB8vfBGQ #orthotwitter Please RT
Single-stage surgery, facilitated by a bioabsorbable local antibiotic, was highly effective in the treatment of chronic osteomyelitis over a prolonged period.
#infection#antibiotics#orthopedics#BJJ
https://t.co/w4Ci6O0oZ2
Our study describes a novel robotics dislocation analysis tool to improve surgical implantation parameters and to assess new implant designs that aim to reduce the medial dislocation risk to an acceptable level @_IreneYang_@DrStephenMellon @Robotic_ESP https://t.co/gZFQ0Se8Ln
Great @baskonline complex knee session session to kick off day 3 at @BritOrthopaedic#BOAAC22 Too much fabulous information to take in to think of snapping each brilliant speaker, sorry.
After a brilliant ACF and DPhil with @ndorms, it's time for a new challenge. I'm looking forward to the challenge of leading surgical research in the international @OHDSI community using #realworld data, joining @BartsBoneJoint as an NIHR Academic Clinical Lecturer
Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial @BMJ_Open https://t.co/32z9IV76Ks @hamilton_tw@HPandit_ortho@ndorms
The KARDS trial protocol paper has now been published!
KARDS is an RCT looking at knee replacement versus knee joint distraction for severe knee osteoarthritis, CI @HPandit_ortho
ISRCTN14879004
https://t.co/Wgcntqxmgh
@LeedsCTRU#clinicalresearch
Great study SPAARK @HPandit_ortho @leedshipknee @david_j_beard multicentre RCT no difference between liposomal bupivicaine v normal bupivicaine. Well done team!
RCT found no difference in post-operative recovery associated with the use of peri-articular liposomal bupivacaine compared to bupivacaine hydrochloride, and does not support the use of peri-articular liposomal bupivacaine for knee replacement. https://t.co/3UctNXrStw
@ndorms@HPandit_ortho@NIHRresearch Great to get this work into print. Thanks to the patients, funders, researchers and health care staff who made this happen.